Australia markets closed

vTv Therapeutics Inc. (VTVT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
27.90+0.02 (+0.07%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,000
0
2,018
4,005
6,414
Operating expenses
Research development
12,302
13,595
12,357
13,324
11,015
Selling general and administrative
12,400
11,907
12,201
12,343
7,251
Total operating expenses
24,702
25,502
24,558
25,667
18,266
Operating income or loss
-23,702
-25,502
-22,540
-21,662
-11,852
Interest expense
-
13
15
12
692
Total other income/expenses net
-2,847
-923
-2,670
4,057
-270
Income before tax
-26,111
-25,966
-24,873
-17,616
-12,802
Income tax expense
100
0
200
115
0
Income from continuing operations
-26,211
-25,966
-25,073
-17,731
-12,802
Net income
-20,616
-20,250
-19,164
-12,987
-8,499
Net income available to common shareholders
-20,616
-20,250
-19,164
-12,987
-8,499
Basic EPS
-10.80
-9.71
-9.98
-8.29
-7.20
Diluted EPS
-10.80
-9.71
-9.98
-8.29
-7.20
Basic average shares
2,038
2,085
1,920
1,566
1,178
Diluted average shares
2,038
2,085
1,920
1,566
1,178